Literature DB >> 2863781

Recent developments in the treatment of acromegaly.

D K Lüdecke.   

Abstract

In acromegaly the microsurgical transsphenoidal removal of the pituitary adenoma has become the most widely used method of treatment. In experienced hands, the therapeutic goal of rapid normalization of hormone excess and preservation of pituitary function can be achieved in most of the patients if the tumours are not too large. Medical treatment or radiotherapy alone, or in combination, are less successful for primary treatment. They are indispensable as alternative therapy in those patients not suitable for operation, and as additional methods after incomplete tumour removal. Large invasive adenomas still present a challenge for further improvement of therapeutic facilities. Intraoperative GH-measurements, as recently introduced by us, help to identify tumour residues and justify additional surgical exploration at higher risk.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2863781     DOI: 10.1007/bf01815441

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  24 in total

1.  Conventional radiation therapy in acromegaly. A review and reassessment.

Authors:  A M Lawrence; S M Pinsky; I D Goldfine
Journal:  Arch Intern Med       Date:  1971-09

2.  A decade of pituitary microsurgery. The Herbert Olivecrona lecture.

Authors:  C B Wilson
Journal:  J Neurosurg       Date:  1984-11       Impact factor: 5.115

3.  Acromegaly: analysis of 132 cases treated surgically.

Authors:  S Balagura; P Derome; G Guiot
Journal:  Neurosurgery       Date:  1981-04       Impact factor: 4.654

4.  Cryosurgery or microsurgery in the management of acromegaly.

Authors:  G M Teasdale; I D Hay; G H Beasttall; D C McCruden; J A Thomson; D L Davies; K W Grossart; J G Ratcliffe
Journal:  JAMA       Date:  1982-03-05       Impact factor: 56.272

5.  Transsphenoidal microsurgical removal of growth hormone-secreting pituitary adenomas. A review of 137 cases.

Authors:  D S Baskin; J E Boggan; C B Wilson
Journal:  J Neurosurg       Date:  1982-05       Impact factor: 5.115

6.  Efficacy of cryohypophysectomy in the treatment of acromegaly. Evaluation of 54 cases.

Authors:  M V DiTullio; R W Rand
Journal:  J Neurosurg       Date:  1977-01       Impact factor: 5.115

7.  Conventional supervoltage irradiation is an effective treatment for acromegaly.

Authors:  R C Eastman; P Gorden; J Roth
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

8.  Effectiveness of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states.

Authors:  G Verde; P G Chiodini; A Liuzzi; R Cozzi; F Favales; L Botalla; B Spelta; D Dalla Bonzana; E Rainer; R Horowski
Journal:  J Endocrinol Invest       Date:  1980 Oct-Dec       Impact factor: 4.256

9.  Circadian variation of basal plasma growth hormone in man.

Authors:  E C Drobny; K Amburn; G Baumann
Journal:  J Clin Endocrinol Metab       Date:  1983-09       Impact factor: 5.958

10.  Interstitial pituitary irradiation with 90Y for the treatment of acromegaly. A reappraisal.

Authors:  J Cassar; F H Doyle; L M Banks; A Jadresic; K Mashiter; G F Joplin
Journal:  Acta Endocrinol (Copenh)       Date:  1981-03
View more
  5 in total

1.  The choice of treatment after incomplete adenomectomy in acromegaly: proton--versus high voltage radiation.

Authors:  D K Lüdecke; B S Lutz; G Niedworok
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

Review 2.  Cushing's disease: a surgical view.

Authors:  D K Lüdecke; J Flitsch; U J Knappe; W Saeger
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

3.  Postoperative controls in surgically treated hormonactive pituitary adenomas by use of magnetic resonance imaging.

Authors:  R Oeckler; U Fink
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

4.  Pituitary adenomas in acromegaly: Comparison of different adenoma types with clinical data.

Authors:  D Voit; W Saeger; D K Lüdecke
Journal:  Endocr Pathol       Date:  1999-06       Impact factor: 3.943

5.  First but not second postoperative day growth hormone assessments as early predictive tests for long-term acromegaly persistence.

Authors:  V Cambria; G Beccuti; N Prencipe; F Penner; V Gasco; F Gatti; M Romanisio; M Caputo; E Ghigo; F Zenga; S Grottoli
Journal:  J Endocrinol Invest       Date:  2021-04-10       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.